Company Management
Alton L. Boynton, Ph.D.(aged 64) President; Chief Executive Officer
Dr. Boynton co-founded the Company and has served as its Chief Scientific Officer and as a director since 1998. Dr. Boynton was appointed as Chief Operating Officer in August 2001, President in May 2003, and Chief Executive Officer in May 2007. Dr. Boynton has also served as director of the Department of Molecular Medicine of Northwest Hospital from 1995 to 2003 where he coordinated the establishment of a program centered on carcinogenesis. Prior to moving to Seattle, Dr. Boynton was associate director of the Cancer Research Center of Hawaii at The University of Hawaii, where he also held the positions of director of Molecular Oncology of the Cancer Research Center and professor of Genetics and Molecular Biology.
Marnix L. Bosch, Ph.D.(aged 48) Chief Technical Officer
Dr. Bosch joined the Company in 2000 and served as Vice President for Vaccine R&D from July 2001 to December 2006. Dr. Bosch currently serves as the Company's Chief Technical Officer. Prior to joining the Company, Dr. Bosch was a member of the faculty of the Department of Pathobiology at the University of Washington and he continues to serve that Department as an Affiliate Associate Professor. He worked at the National Institutes of Health (Bethesda, MD) and the National Institutes of Health and Environmental Protection (Bilthoven, the Netherlands) prior to joining the University of Washington. He has authored more than 40 research publications in virology and immunology, and is an inventor on several patent applications on dendritic cell product manufacturing. Dr. Bosch obtained his Ph.D. in Medicine at the University of Leiden, the Netherlands, in 1987 and earned an MBA from the University of Washington in 2003.
|
